Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Kizuna centrosomal protein (KIZ) is an intracellular protein encoded by the KIZ gene, primarily localized to the centrosome[1][2][3][6][10]. It plays a critical role in maintaining the structural integrity and cohesion of the pericentriolar material (PCM) during mitosis by stabilizing spindle poles and preventing centrosomal fragmentation under microtubule-generated stresses[2][3]. Kizuna is phosphorylated by Polo-like kinase 1 (Plk1) and retains association with the mother centrosome after duplication[2][9]. Disruption of KIZ function leads to defective spindle formation and chromosomal missegregation, as well as defects in ciliary function at the basal body[2]. Mutations in KIZ cause autosomal recessive rod-cone dystrophy and have been linked to retinitis pigmentosa, implicating its importance in retinal sensory cell maintenance[1][2][3]. No direct evidence identifies KIZ as a therapeutic target, nor are there known drugs or biomarker roles directly associated with it[3][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Kizuna centrosomal protein (KIZ).